Partner Dan Shores will lead a session titled "An Overview of the Intellectual Property Trends for LNPs Including New Targeting Technologies" at the 5th Annual LNP Formulation & Process Development Summit taking place April 6-8, 2026, in Boston, Massachusetts. Dan's workshop will take place on April 6 during the Pre-Conference LNP 101 Day.
Dan's session will cover:
- Managing the crowded patent landscapes to secure and navigate third party rights relating to lipids, formulations, and delivery innovations;
- Delving into the targeting moieties and other technologies which are driving and evolving the IP landscape; and
- Discussing the analytical framework for protecting the IP generated by research teams.
As the LNP field continues to expand, from mRNA vaccines to cutting-edge cell and gene therapies, the 5th LNP Formulation & Process Development Summit returns to Boston in April 2026. Curated in collaboration the Scientific Advisory Board, this premier forum is designed to deliver LNP-specific networking and knowledge sharing. Join LNP innovators to advance extrahepatic targeting, stable formulation design, robust analytical characterization, and consistent large-scale manufacturing to accelerate LNP-based therapeutics to the market.
To learn more about the event, and to register, please visit the event website.
